DCBs could become 'standard of care' for peripheral in-stent restenosis - Healio

DCBs could become 'standard of care' for peripheral in-stent restenosis  Healio

HOLLYWOOD, Fla. — Drug-coated balloons have the strongest evidence, compared with other technologies, as a solution for peripheral in-stent restenosis, ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more